07242017Headline:

Ohio Valley, West Virginia

HomeWest VirginiaOhio Valley

Email Roopal Luhana Roopal Luhana on Twitter
Roopal Luhana
Roopal Luhana
Attorney • (888) 480-1123

Meeting Scheduled to Review Risperdal Claims in Philadelphia

1 comment

A number of lawsuits have been filed against Risperdal manufacturer Janssen Pharmaceuticals and parent company Johnson & Johnson (J&J). Plaintiffs claim that the drug companies failed to provide adequate warnings about the risks of the anti-psychotic medication, including its potential to cause gynecomastia (abnormal breast growth) in boys.

Estimates are that over 400 Risperdal lawsuits have been filed against J&J, with most of those pending in the Philadelphia Court of Common pleas, though several have also been consolidated in Middlesex County in New Jersey. Some of those cases have already been settled, but more new cases continue to be filed. Now, the Pennsylvania court has scheduled a meeting for May 13, 2014, to consider claims regarding the medication.

Risperdal Allegedly Caused Serious Side Effects

Originally approved to treat schizophrenia in adults, Risperdal did not receive FDA approval for use in children until 2006, and then, only in those with autism. In 2007, the agency approved its use in children ages 13-17 with schizophrenia, or in those 10-17 with bipolar disorder.

Some of the plaintiffs filing Risperdal lawsuits, however, state that they were prescribed the medication “off-label” before 2006, and were never warned about the potential for gynecomastia. In one of the cases, for example, the plaintiff claims that he took the drug between 1999 and 2004, after which he experienced embarrassing breast growth. (Banks vs. v. Janssen Pharmaceuticals, Philadelphia Court of Common Pleas, January Term 2010, No. 00618)

Other plaintiffs that have endured the same side effects had to go through surgery to have the excess breast tissue removed. Some allegedly suffered from emotional and psychological wounds, and endured teasing and bullying in school.

Studies Confirm Risperdal/Gynecomastia Link

Studies have confirmed the link between Risperdal (risperidone) and gynecomastia. In a 2006 study, for example, researchers found that the drug caused a rise in “prolactin” levels. Prolactin is a hormone that stimulates breast development and milk production. A second study the same year found similar results.

In 2007, researchers discovered that regular doses of the drug created a four-fold increase in prolactin levels in children. In a later 2009 study, researchers found that those levels could remain high for up to two years after treatment in children and adolescents.

Plaintiffs involved in Risperdal lawsuits claim the company was aware of these connections, but failed to adequately warn physicians or patients of the potential dangers. They add that the manufacturers made a point of marketing the medications to pediatricians, overstating the benefits while failing to be up front about the risks.

J&J Has Already Paid

J&J has already paid for its alleged overpromotion of Risperdal. In November 2013, they shelled out $2.2 million to resolve claims brought forth by the U.S. Department of Justice. According to a press release created by the Department, the money was paid to “resolve criminal and civil liability arising from allegations relating to the prescription drugs Risperdal, Invega and Natrecor, including promotion for uses not approved as safe by and effective by the Food and Drug Administration (FDA) and payment of kickbacks to physicians and to the nation’s largest long-term care pharmacy provider.” The Department went on to state that the company had put the health and safety of patients at risk.

1 Comment

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

  1. Julie Greene says:
    up arrow

    I am female and have experienced gallactorrhea from Risperdal.. It’s my understanding that many psychiatric drugs will raise prolactin, and Risperdal is one of the worst. An elevated prolactin level will stop a woman’s periods very easily. This happened to me. I didn’t want to admit, though I was aware, that Risperdal was the cause. Then, when I broke my leg in 1999, the orthopedist who screwed the bone back together was shocked at the condition of my bones. He said, and I quote, “They are like balsa wood.” Later in my 40’s, I began to get regular mammograms. At this point, it was clear that my breasts were producing an immense amount of milk. The mammogram machine pushed the milk out right onto the floor! The technicians said they had seen this only in patients who take certain medications. It’s like you are pregnant and full of milk. When I took Imipramine in 2011 and 2012 I noticed the exact same thing happening. Please, elevated prolactin is no joke, even though doctors will tell you it’s “nothing” or a “trade-off”! Baloney! You don’t want to lose your bones! Bone thinning can cause severe pain and it can put you in a wheelchair or even into a nursing home! Don’t take these drugs!